ATE225181T1 - Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen - Google Patents
Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemenInfo
- Publication number
- ATE225181T1 ATE225181T1 AT98925774T AT98925774T ATE225181T1 AT E225181 T1 ATE225181 T1 AT E225181T1 AT 98925774 T AT98925774 T AT 98925774T AT 98925774 T AT98925774 T AT 98925774T AT E225181 T1 ATE225181 T1 AT E225181T1
- Authority
- AT
- Austria
- Prior art keywords
- molecular weight
- low molecular
- treatment
- brain edema
- weight heparins
- Prior art date
Links
- 206010048962 Brain oedema Diseases 0.000 title abstract 2
- 208000006752 brain edema Diseases 0.000 title abstract 2
- 229940127215 low-molecular weight heparin Drugs 0.000 title abstract 2
- 239000003055 low molecular weight heparin Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9706551A FR2763849B1 (fr) | 1997-05-28 | 1997-05-28 | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux |
| PCT/FR1998/001035 WO1998053834A1 (fr) | 1997-05-28 | 1998-05-25 | Utilisation des heparines de bas poids moleculaire pour la prevention et le traitement des oedemes cerebraux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE225181T1 true ATE225181T1 (de) | 2002-10-15 |
Family
ID=9507336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98925774T ATE225181T1 (de) | 1997-05-28 | 1998-05-25 | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6579858B1 (de) |
| EP (1) | EP0984787B1 (de) |
| JP (1) | JP2002502387A (de) |
| KR (1) | KR100562425B1 (de) |
| CN (1) | CN1223351C (de) |
| AT (1) | ATE225181T1 (de) |
| AU (1) | AU742995B2 (de) |
| BR (1) | BR9809180A (de) |
| CA (1) | CA2290682A1 (de) |
| DE (1) | DE69808455T2 (de) |
| DK (1) | DK0984787T3 (de) |
| ES (1) | ES2182321T3 (de) |
| FR (1) | FR2763849B1 (de) |
| IL (2) | IL132670A0 (de) |
| MA (1) | MA24554A1 (de) |
| NO (1) | NO317003B1 (de) |
| NZ (1) | NZ501366A (de) |
| PE (1) | PE73099A1 (de) |
| PT (1) | PT984787E (de) |
| RU (1) | RU2195287C2 (de) |
| TN (1) | TNSN98072A1 (de) |
| TW (1) | TW546141B (de) |
| WO (1) | WO1998053834A1 (de) |
| ZA (1) | ZA984433B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2787329B1 (fr) * | 1998-12-17 | 2001-02-09 | Aventis Pharma Sa | Nouvelle application therapeutique des heparines de bas poids moleculaire |
| JP2005505537A (ja) * | 2001-08-28 | 2005-02-24 | レオ・ファーマ・アクティーゼルスカブ | 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物 |
| RU2238737C1 (ru) * | 2003-04-17 | 2004-10-27 | Закрытое Акционерное Общество Научно-Производственный Центр "Борщаговский Химико-Фармацевтический Завод" | Препарат "веногепанол" для лечения и профилактики патологических поражений сосудов и тканей |
| ITMI20031023A1 (it) * | 2003-05-21 | 2004-11-22 | Umberto Cornelli | Glicosaminoglicani aventi peso molecolare medio 2400 d atti al trattamento delle disfunzioni emozionali. |
| US11840565B2 (en) | 2016-12-29 | 2023-12-12 | University Of Miami | Methods and compositions for treating virus-associated inflammation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2013092C1 (ru) * | 1989-02-27 | 1994-05-30 | Дагестанский государственный медицинский институт | Способ лечения отека мозга при туберкулезном менингоэнцефалите |
-
1997
- 1997-05-28 FR FR9706551A patent/FR2763849B1/fr not_active Expired - Fee Related
-
1998
- 1998-05-19 PE PE1998000385A patent/PE73099A1/es not_active Application Discontinuation
- 1998-05-25 TW TW087108064A patent/TW546141B/zh not_active IP Right Cessation
- 1998-05-25 JP JP50031199A patent/JP2002502387A/ja not_active Ceased
- 1998-05-25 MA MA25089A patent/MA24554A1/fr unknown
- 1998-05-25 KR KR1019997011052A patent/KR100562425B1/ko not_active Expired - Fee Related
- 1998-05-25 RU RU99128103/14A patent/RU2195287C2/ru not_active IP Right Cessation
- 1998-05-25 NZ NZ501366A patent/NZ501366A/xx unknown
- 1998-05-25 AU AU77760/98A patent/AU742995B2/en not_active Ceased
- 1998-05-25 AT AT98925774T patent/ATE225181T1/de not_active IP Right Cessation
- 1998-05-25 DE DE69808455T patent/DE69808455T2/de not_active Expired - Lifetime
- 1998-05-25 CA CA002290682A patent/CA2290682A1/fr not_active Abandoned
- 1998-05-25 CN CNB988054906A patent/CN1223351C/zh not_active Expired - Fee Related
- 1998-05-25 PT PT98925774T patent/PT984787E/pt unknown
- 1998-05-25 ES ES98925774T patent/ES2182321T3/es not_active Expired - Lifetime
- 1998-05-25 BR BR9809180-8A patent/BR9809180A/pt not_active Application Discontinuation
- 1998-05-25 DK DK98925774T patent/DK0984787T3/da active
- 1998-05-25 EP EP98925774A patent/EP0984787B1/de not_active Expired - Lifetime
- 1998-05-25 ZA ZA984433A patent/ZA984433B/xx unknown
- 1998-05-25 IL IL13267098A patent/IL132670A0/xx unknown
- 1998-05-25 WO PCT/FR1998/001035 patent/WO1998053834A1/fr not_active Ceased
- 1998-05-27 TN TNTNSN98072A patent/TNSN98072A1/fr unknown
-
1999
- 1999-11-01 IL IL132670A patent/IL132670A/en not_active IP Right Cessation
- 1999-11-12 NO NO19995539A patent/NO317003B1/no not_active IP Right Cessation
- 1999-11-29 US US09/450,110 patent/US6579858B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PT984787E (pt) | 2003-01-31 |
| TW546141B (en) | 2003-08-11 |
| NZ501366A (en) | 2000-11-24 |
| CA2290682A1 (fr) | 1998-12-03 |
| JP2002502387A (ja) | 2002-01-22 |
| IL132670A0 (en) | 2001-03-19 |
| TNSN98072A1 (fr) | 2005-03-15 |
| MA24554A1 (fr) | 1998-12-31 |
| DE69808455D1 (de) | 2002-11-07 |
| US6579858B1 (en) | 2003-06-17 |
| DE69808455T2 (de) | 2003-07-03 |
| NO995539D0 (no) | 1999-11-12 |
| ES2182321T3 (es) | 2003-03-01 |
| KR100562425B1 (ko) | 2006-03-17 |
| FR2763849B1 (fr) | 2000-09-15 |
| AU742995B2 (en) | 2002-01-17 |
| IL132670A (en) | 2010-05-31 |
| PE73099A1 (es) | 1999-10-21 |
| EP0984787B1 (de) | 2002-10-02 |
| RU2195287C2 (ru) | 2002-12-27 |
| EP0984787A1 (de) | 2000-03-15 |
| CN1223351C (zh) | 2005-10-19 |
| FR2763849A1 (fr) | 1998-12-04 |
| WO1998053834A1 (fr) | 1998-12-03 |
| ZA984433B (en) | 1998-12-28 |
| DK0984787T3 (da) | 2003-02-03 |
| KR20010013073A (ko) | 2001-02-26 |
| CN1257429A (zh) | 2000-06-21 |
| BR9809180A (pt) | 2000-08-01 |
| NO995539L (no) | 1999-11-12 |
| NO317003B1 (no) | 2004-07-19 |
| AU7776098A (en) | 1998-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
| DE69736183D1 (de) | Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| ATE258796T1 (de) | Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen | |
| DE69635708D1 (de) | Tetrandrin zur behandlung von augenentzündungen | |
| DE69834724D1 (de) | Behandlung von Darm- oder Blasenentzündungen | |
| DE69825440D1 (de) | VERWENDUNG VON TAUROLIDINE ZUR Herstellung eines Arzneimittels zur BEHANDLUNG VON LEUKÄMIEN | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
| DE69619051D1 (de) | Behandlung von Füllstoffen mit Oxasilacycloalkanen | |
| DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
| DE69313261D1 (de) | Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS | |
| DE69924979D1 (de) | Behandlung von chronischen schmerzen | |
| DE69429013D1 (de) | Verwendung von dimeticon zur behandlung der konstipation | |
| ATE369143T1 (de) | Verwendung von ngali nussöl zur behandlung/linderung der arthritisschmerzen und anderer ähnlichen störungen | |
| DE69919578D1 (de) | VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten | |
| DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine | |
| ATE216884T1 (de) | Verwendung von sulbutiamin zur behandlung von psychomotorischen oder psychointellektuellen beschwerden | |
| ATE72115T1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a- | |
| ATE209910T1 (de) | Verwendung von 6,7-substituierter 2- aminotetraline zur behandlung von zytokin- vermittleten entzündungszuständen | |
| EA199800818A1 (ru) | Способ лечения бессонницы | |
| DE68906028D1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
| ATE88090T1 (de) | Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom. | |
| ATE96129T1 (de) | Behandlung von abwasser. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0984787 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |